Effects of Cholinesterase Inhibitors in Parkinson's Disease Dementia: A Review of Clinical Data

Aims: Cognitive impairment and dementia are common features of Parkinson's disease (PD). Patients with Parkinson's disease dementia (PDD) often have significant cholinergic defects, which may be treated with cholinesterase inhibitors (ChEIs). The objective of this review was to consider av...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:CNS Neurosci Ther
Hlavní autoři: van Laar, Teus, De Deyn, Peter Paul, Aarsland, Dag, Barone, Paolo, Galvin, James E
Médium: Artigo
Jazyk:Inglês
Vydáno: Blackwell Publishing Ltd 2010
Témata:
Reviews
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6493905/
https://ncbi.nlm.nih.gov/pubmed/21951368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1755-5949.2010.00166.x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky